-
Public health experts say the official number of heat deaths is an undercount as 20 to 30 per cent of heat stroke cases usually result in fatalities.
-
21 cases of the JN.1 variant detected, with 19 cases in Goa and one each in Kerala and Maharashtra. Doctors are on high alert, urging precautions. The World Health Organization has classified JN.1 as a 'variant of interest. Sherine Elizabeth of CNN_News18 speaks to Former WHO Scientist Soumya Swaminathan.
-
The exit of Soumya Swaminathan, an Indian pediatrician, announced on Twitter, comes as Director-General Tedros Adhanom Ghebreyesus's second term as leader of the 74-year-old U.N. agency gets underway. Swaminathan did not give a reason.
-
R. Vaishali and Tania Sachdev have scored 3.5/4 game points each, meaning they have conceded only one draw each in their first four outings, while Bhakti Kulkarni, has won all the three games so far.
-
There is mounting evidence that suggests that Omicron subvariants BA.4 and BA.5 are infecting people who have been vaccinated.
-
Speaking in a panel discussion as part of BioAsia 2022, she said though several high-end countries have completed vaccination to the extent of 90 per cent some of the nations in Africa have completed only 10 per cent inoculation even as there was ease on vaccine supply side globally.
-
'What we can expect to see in India is a surge of Omicron cases. I think it is just the beginning now in some of the cities and is going to infect a lot of people'
-
The EUL process conducted by WHO and the Technical Advisory Group of independent experts is centred on determining if a manufactured product (COVID vaccine in this case) is quality-assured, safe and effective.
-
'We may be entering some kind of stage of endemicity where there is low level transmission or moderate level transmission going on but we are not seeing the kinds of exponential growth and peaks that we saw a few months ago,' Swaminathan said.
-
WHO doesn't have the information necessary to make the recommendation on whether or not a booster will be needed, Swaminathan has said.
-
'The Delta variant is well on its way to becoming the dominant variant globally because of its increased transmissibility,' Swaminathan told a news conference.
-
When M.S. Swaminathan, known as the Father of India’s Green Revolution, faced criticism about the effects of pesticides, he did not take it the wrong way but looked for solutions instead, she remembers.
-
"All available vaccines reduce severity of infection," Soumya Swaminathan while speaking on India's double mutant variant, adding that even if a person contracts COVID-19 after getting vaccinated, the infection is mild in most cases.
-
Swaminathan, an Indian paediatrician and clinical scientist, said the B.1.617 variant of COVID-19, which was first detected in India last October, was clearly a contributing factor to the catastrophe unfolding in her homeland.
-
Infections numbers are surging around the world, especially in Europe where nations have been forced to ramp up virus restrictions even as vaccines are rolled out.
-
To date 189 countries have joined the COVAX programme, which is backed by the WHO and seeks to ensure equitable distribution of vaccines. The United States is not among them, having secured bilateral deals.
-
On vaccine development for the novel coronavirus, Soumya Swaminathan said: "By early 2021, we should have some good news."
-
President Donald Trump on Sunday approved an emergency authorisation of convalescent plasma for COVID-19 patients.
-
The Chief Scientist of WHO, Soumya Swaminathan, in an interactive session through video conference said,as of now about 28 vaccine candidates for COVID-19 are under clinical trial, of which five are entering Phase-II and over 150 candidates are in pre-clinical trials across the globe.
-
Swaminathan, answering questions on social media platforms, also said testing vaccines for safety and efficacy - usually a years-long process - could be accelerated to just six months in the midst of the pandemic, if data satisfied regulators that they have enough information to issue approvals.
